Patents Represented by Attorney Rogers & Gray LLP

Find this attorney in the Justia Lawyer Directory

  • Imidazo[2,1-]-1,3,4-thiadiazole sulfonamides
    Patent number: 7714003
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: May 11, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley E. Hewitt
  • Hepatitis C virus variants
    Patent number: 7705138
    Abstract: The present invention relates to HCV variants, particularly variants that are resistant to a protease inhibitors such as VX-950. Also provided are methods and compositions related to the HCV variants. Further provided are methods of isolating, identifying, and characterizing multiple viral variants from a patient.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: April 27, 2010
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Chao Lin, Tara Kieffer, Christoph Sarrazin, Ann Kwong